{"name":"Regenexx, LLC","slug":"regenexx-llc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Bone Marrow Concentrate treatment","genericName":"Bone Marrow Concentrate treatment","slug":"bone-marrow-concentrate-treatment","indication":"Other","status":"phase_1"}]},{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Regenexx SD® procedure","genericName":"Regenexx SD® procedure","slug":"regenexx-sd-procedure","indication":"Osteoarthritis of the knee","status":"phase_3"}]}],"pipeline":[{"name":"Bone Marrow Concentrate treatment","genericName":"Bone Marrow Concentrate treatment","slug":"bone-marrow-concentrate-treatment","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Regenexx SD® procedure","genericName":"Regenexx SD® procedure","slug":"regenexx-sd-procedure","phase":"phase_3","mechanism":"Regenexx SD uses autologous bone marrow-derived stem cells to promote tissue regeneration and reduce inflammation in degenerative joint conditions.","indications":["Osteoarthritis of the knee","Osteoarthritis of the hip","Osteoarthritis of the shoulder","Degenerative disc disease of the spine"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxNd1pyc3lxNXVweVV4ZlptODE0SHU0SlhMdms1c0UwdFBGUDFyZTN4XzRHcXdDcTVCNl9TeWliQVFhek0ybHc2NFhMYnNCa25BM09SdFhaWk50Q0lJb3pOOXcteVoxN0xYUnFvSVhwS0dDb3RETVpJNVNJdWMtYjA0eVMzVlVJdXlxbUJqdl9hQUZZQXppVzJZRHd5Nmhyb1ZnQWo3NU9ycXFfM2M?oc=5","date":"2014-02-06","type":"regulatory","source":"Buchanan Ingersoll & Rooney","summary":"Recent Case Upholds FDA’s Jurisdiction over Cell and Tissue Product Regulation - Buchanan Ingersoll & Rooney","headline":"Recent Case Upholds FDA’s Jurisdiction over Cell and Tissue Product Regulation - Buchanan Ingersoll & Rooney","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_1":1,"phase_3":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}